ZAFIRLUKAST

ZAFIRLUKAST was reported 907 times

ZAFIRLUKAST is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FUNGAL TEST 9 0.6923
1 BLINDNESS HYSTERICAL 1 0.3333
2 ADMINISTRATION SITE JOINT ERYTHEMA 1 0.1250
3 ELECTROPHORESIS PROTEIN 1 0.0909
4 PROLONGED EXPIRATION 19 0.0725
5 ANKLE BRACHIAL INDEX DECREASED 1 0.0370
6 HYPERGEUSIA 2 0.0339
7 DIFFUSE CUTANEOUS MASTOCYTOSIS 1 0.0333
8 SPUTUM PURULENT 20 0.0304
9 COLOUR VISION TESTS ABNORMAL 2 0.0303
10 PRECANCEROUS CONDITION 19 0.0284
11 ENCHONDROMATOSIS 2 0.0233
12 ANALGESIC DRUG LEVEL DECREASED 1 0.0227
13 LIGAMENTUM FLAVUM HYPERTROPHY 1 0.0217
14 BOWEL OBSTRUCTION SURGERY 1 0.0182
15 BRAIN LOBECTOMY 1 0.0169
16 INTRADUCTAL PAPILLARY-MUCINOUS CARCINOMA OF PANCREAS 1 0.0154
17 MEDICAL DEVICE SITE ABSCESS 1 0.0145
18 URTICARIA THERMAL 2 0.0141
19 ALPHA 1 GLOBULIN INCREASED 1 0.0125
20 ATYPICAL MYCOBACTERIUM TEST POSITIVE 1 0.0103
21 ENCAPSULATION REACTION 1 0.0097
22 INTERVERTEBRAL DISC ANNULAR TEAR 1 0.0094
23 VASCULAR ACCESS SITE COMPLICATION 2 0.0079
24 PASTEURELLA INFECTION 1 0.0078
25 BRONCHOMALACIA 1 0.0076
26 ABDOMINAL WALL INFECTION 1 0.0075
27 ALLERGIC RESPIRATORY DISEASE 1 0.0072
28 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 3 0.0070
29 MENISCUS REMOVAL 1 0.0068
30 MONONEURITIS 1 0.0064
31 AUTOIMMUNE MYOSITIS 3 0.0064
32 ADMINISTRATION SITE SWELLING 2 0.0062
33 FORCED VITAL CAPACITY DECREASED 4 0.0061
34 GALLBLADDER HYPOFUNCTION 1 0.0058
35 PITUITARY APOPLEXY 1 0.0057
36 CHRONIC SINUSITIS 21 0.0056
37 PERIORBITAL DISORDER 1 0.0049
38 ALLERGIC GRANULOMATOUS ANGIITIS 4 0.0049
39 CORNEAL GRAFT REJECTION 1 0.0048
40 EXPOSURE TO FUNGUS 1 0.0047
41 HIGH DENSITY LIPOPROTEIN ABNORMAL 1 0.0043
42 SINUS OPERATION 10 0.0042
43 DERMATITIS HERPETIFORMIS 1 0.0041
44 BODY MASS INDEX ABNORMAL 1 0.0041
45 PLANTAR ERYTHEMA 1 0.0040
46 PHARYNGEAL MASS 2 0.0038
47 ATOPY 1 0.0036
48 PRODUCT APPEARANCE CONFUSION 3 0.0032
49 NASAL CRUSTING 2 0.0031
50 CATHETER SITE BRUISE 1 0.0030
51 CENTRAL NERVOUS SYSTEM INFLAMMATION 1 0.0030
52 ALLERGIC RESPIRATORY SYMPTOM 1 0.0030
53 ARRHYTHMIC STORM 1 0.0030
54 RHONCHI 4 0.0029
55 MUSCLE HYPERTROPHY 1 0.0028
56 CORONARY ARTERY INSUFFICIENCY 1 0.0028
57 CENTRAL OBESITY 2 0.0027
58 BASOPHIL COUNT INCREASED 2 0.0026
59 LUNG ADENOCARCINOMA STAGE IV 1 0.0026
60 BONE TUBERCULOSIS 1 0.0026
61 ASYMPTOMATIC COVID-19 1 0.0025
62 KETONURIA 2 0.0025
63 NORMAL PRESSURE HYDROCEPHALUS 1 0.0024
64 SPUTUM DISCOLOURED 23 0.0024
65 ANAEMIA HAEMOLYTIC AUTOIMMUNE 2 0.0024
66 SCIATIC NERVE INJURY 2 0.0024
67 PEAK EXPIRATORY FLOW RATE DECREASED 1 0.0023
68 ANOGENITAL WARTS 2 0.0022
69 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
70 MUSCLE SWELLING 2 0.0022
71 EHLERS-DANLOS SYNDROME 1 0.0022
72 AUDITORY DISORDER 3 0.0021
73 ANIMAL SCRATCH 2 0.0021
74 ECZEMA NUMMULAR 1 0.0020
75 MARKEDLY REDUCED DIETARY INTAKE 1 0.0020
76 BRAIN STEM STROKE 1 0.0020
77 LENTIGO 1 0.0020
78 DYSPNOEA EXACERBATED 1 0.0019
79 INSULIN-LIKE GROWTH FACTOR DECREASED 1 0.0019
80 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
81 EMPHYSEMA 19 0.0019
82 COATING IN MOUTH 1 0.0019
83 LEFT ATRIAL ENLARGEMENT 1 0.0019
84 HYPERTROPHY 1 0.0018
85 HYPERAMYLASAEMIA 1 0.0018
86 BURNING MOUTH SYNDROME 1 0.0018
87 PERFUME SENSITIVITY 1 0.0018
88 PERIPHERAL EMBOLISM 2 0.0017
89 MOTOR DEVELOPMENTAL DELAY 1 0.0017
90 SKIN HYPOPIGMENTATION 3 0.0017
91 ENDOTRACHEAL INTUBATION COMPLICATION 1 0.0017
92 RECTAL PROLAPSE 2 0.0017
93 BLADDER PROLAPSE 2 0.0016
94 LOW DENSITY LIPOPROTEIN ABNORMAL 1 0.0016
95 MEDICAL DEVICE SITE INFECTION 1 0.0016
96 LIPOHYPERTROPHY 1 0.0016
97 MALLORY-WEISS SYNDROME 2 0.0016
98 APHONIA 22 0.0016
99 MUCOSAL DISCOLOURATION 1 0.0016
100 PULMONARY MASS 23 0.0015
101 HIRSUTISM 2 0.0015
102 MAMMOGRAM ABNORMAL 1 0.0015
103 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
104 HIATUS HERNIA 19 0.0015
105 HYPERPARATHYROIDISM 3 0.0015
106 CUSHING'S SYNDROME 1 0.0014
107 MAST CELL ACTIVATION SYNDROME 2 0.0014
108 ATYPICAL MYCOBACTERIAL INFECTION 2 0.0014
109 RESPIRATORY SYMPTOM 4 0.0014
110 SEBORRHOEIC KERATOSIS 2 0.0014
111 DYSPNOEA PAROXYSMAL NOCTURNAL 1 0.0014
112 OROMANDIBULAR DYSTONIA 1 0.0014
113 OSMOTIC DEMYELINATION SYNDROME 1 0.0014
114 SKIN STRIAE 2 0.0013
115 EOSINOPHIL COUNT ABNORMAL 1 0.0013
116 MICROALBUMINURIA 1 0.0013
117 ORAL MUCOSAL EXFOLIATION 2 0.0013
118 MYCOPLASMA INFECTION 1 0.0013
119 NASAL ULCER 2 0.0013
120 LIP ERYTHEMA 1 0.0013
121 VITAMIN B12 DEFICIENCY 5 0.0012
122 PAPILLOMA VIRAL INFECTION 2 0.0012
123 COVID-19 IMMUNISATION 1 0.0012
124 MEAN PLATELET VOLUME DECREASED 1 0.0012
125 LIP PRURITUS 1 0.0012
126 PHYSICAL DECONDITIONING 3 0.0012
127 CYSTOCELE 1 0.0012
128 INFUSION SITE DISCHARGE 2 0.0011
129 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 1 0.0011
130 MONOCYTE COUNT INCREASED 4 0.0011
131 BIOPSY 1 0.0011
132 PENILE SIZE REDUCED 1 0.0011
133 HYPERVIGILANCE 1 0.0010
134 APPLICATION SITE BRUISE 1 0.0010
135 JOINT NOISE 2 0.0010
136 BRAIN HYPOXIA 1 0.0010
137 ISCHAEMIC CARDIOMYOPATHY 3 0.0010
138 IMPAIRED QUALITY OF LIFE 14 0.0010
139 LIVEDO RETICULARIS 2 0.0010
140 OEDEMA MUCOSAL 1 0.0010
141 HYPERTENSIVE NEPHROPATHY 1 0.0009
142 SHOULDER OPERATION 4 0.0009
143 IDIOPATHIC URTICARIA 1 0.0009
144 GALLBLADDER ENLARGEMENT 1 0.0009
145 INFUSION SITE BRUISING 2 0.0009
146 REACTION TO DRUG EXCIPIENTS 2 0.0009
147 KIDNEY ENLARGEMENT 1 0.0009
148 BLADDER DILATATION 1 0.0009
149 LISTERIOSIS 1 0.0009
150 ESSENTIAL TREMOR 1 0.0009
151 CORTISOL DECREASED 1 0.0009
152 NEPHROGENIC ANAEMIA 4 0.0009
153 NECK SURGERY 2 0.0009
154 ASTHMA 96 0.0008
155 URINARY HESITATION 2 0.0008
156 ESCHERICHIA TEST POSITIVE 1 0.0008
157 INFECTED CYST 1 0.0008
158 EYELID SKIN DRYNESS 1 0.0008
159 DYSPNOEA EXERTIONAL 31 0.0008
160 WHEEZING 48 0.0008
161 SUFFOCATION FEELING 2 0.0008
162 ALLERGY TO CHEMICALS 1 0.0008
163 NASAL PRURITUS 1 0.0008
164 HYPERPARATHYROIDISM SECONDARY 2 0.0008
165 NEPHRITIS INTERSTITIAL 1 0.0008
166 FRACTURED COCCYX 1 0.0008
167 NOCTURNAL DYSPNOEA 1 0.0008
168 LIP HAEMORRHAGE 1 0.0008
169 LIBIDO DISORDER 1 0.0008
170 FEELINGS OF WORTHLESSNESS 1 0.0008
171 ACROCHORDON 1 0.0008
172 ANAESTHETIC COMPLICATION 2 0.0007
173 IMMUNOGLOBULINS DECREASED 1 0.0007
174 DISCHARGE 1 0.0007
175 EOSINOPHIL COUNT INCREASED 6 0.0007
176 SEASONAL ALLERGY 10 0.0007
177 APPENDIX DISORDER 1 0.0007
178 BLOOD ELECTROLYTES DECREASED 1 0.0007
179 CHORIORETINOPATHY 1 0.0007
180 INTERVERTEBRAL DISC DISORDER 3 0.0007
181 RESPIRATORY DISORDER 21 0.0007
182 HYPERTONIC BLADDER 2 0.0007
183 DYSPNOEA AT REST 2 0.0007
184 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
185 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
186 PULMONARY FUNCTION TEST DECREASED 3 0.0007
187 DARK CIRCLES UNDER EYES 1 0.0007
188 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
189 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
190 EPICONDYLITIS 1 0.0007
191 INTELLECTUAL DISABILITY 1 0.0007
192 HEAT STROKE 1 0.0007
193 MYOGLOBIN BLOOD INCREASED 1 0.0007
194 GENITAL HERPES 1 0.0007
195 PNEUMONIA PSEUDOMONAL 1 0.0007
196 PRODUCTIVE COUGH 31 0.0006
197 MEDICAL DEVICE IMPLANTATION 1 0.0006
198 INFUSION SITE SWELLING 4 0.0006
199 FUNGAEMIA 1 0.0006
200 CUSHINGOID 2 0.0006
201 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
202 OPTIC ATROPHY 1 0.0006
203 PITUITARY TUMOUR BENIGN 1 0.0006
204 OXYGEN THERAPY 1 0.0006
205 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
206 CEREBELLAR INFARCTION 1 0.0006
207 EXPOSURE TO SARS-COV-2 1 0.0006
208 ENTERITIS INFECTIOUS 1 0.0006
209 VARICOSE VEIN 3 0.0006
210 ACUTE SINUSITIS 1 0.0006
211 CARDIAC ABLATION 1 0.0006
212 ESSENTIAL HYPERTENSION 1 0.0005
213 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
214 ALCOHOL USE 2 0.0005
215 NERVE COMPRESSION 5 0.0005
216 UPPER RESPIRATORY TRACT INFECTION 25 0.0005
217 BLOOD CHOLESTEROL DECREASED 1 0.0005
218 BLADDER SPASM 1 0.0005
219 LIP DISORDER 1 0.0005
220 HYPERCOAGULATION 1 0.0005
221 SKIN ATROPHY 3 0.0005
222 OPTIC ISCHAEMIC NEUROPATHY 2 0.0005
223 EARLY SATIETY 1 0.0005
224 NASAL SEPTUM DEVIATION 1 0.0005
225 MULTIPLE ALLERGIES 4 0.0005
226 PROSTATOMEGALY 2 0.0005
227 PLEURISY 3 0.0005
228 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 24 0.0005
229 RHINITIS 4 0.0005
230 ENURESIS 2 0.0005
231 DEVICE DEPOSIT ISSUE 1 0.0005
232 PERIPHERAL VENOUS DISEASE 2 0.0005
233 CHANGE OF BOWEL HABIT 1 0.0005
234 SCOLIOSIS 3 0.0005
235 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
236 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
237 PHARYNGEAL ERYTHEMA 1 0.0005
238 SLEEP APNOEA SYNDROME 9 0.0005
239 FOREIGN BODY SENSATION IN EYES 3 0.0005
240 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
241 LANGUAGE DISORDER 1 0.0005
242 OCULAR ICTERUS 2 0.0005
243 CERVICAL DYSPLASIA 1 0.0005
244 LIMB MASS 1 0.0005
245 DIABETIC NEPHROPATHY 1 0.0005
246 BACTERIAL TEST POSITIVE 1 0.0004
247 FEAR OF DEATH 1 0.0004
248 KOUNIS SYNDROME 1 0.0004
249 PERIARTHRITIS 1 0.0004
250 HAEMATOCRIT INCREASED 1 0.0004
251 DYSPAREUNIA 2 0.0004
252 ORAL PRURITUS 1 0.0004
253 INCREASED TENDENCY TO BRUISE 4 0.0004
254 SYNOVIAL CYST 2 0.0004
255 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
256 HAEMANGIOMA 1 0.0004
257 UMBILICAL HERNIA 2 0.0004
258 EOSINOPHIL COUNT DECREASED 1 0.0004
259 DIABETES INSIPIDUS 1 0.0004
260 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
261 NOCTURIA 5 0.0004
262 BRONCHITIS CHRONIC 1 0.0004
263 HAEMATOLOGICAL INFECTION 1 0.0004
264 DERMAL CYST 1 0.0004
265 INSTILLATION SITE PAIN 1 0.0004
266 INJECTION SITE INFLAMMATION 2 0.0004
267 CHEST DISCOMFORT 41 0.0004
268 OSTEITIS 1 0.0004
269 EXCORIATION 1 0.0004
270 PATHOLOGICAL FRACTURE 2 0.0004
271 ABDOMINAL INFECTION 1 0.0004
272 AORTIC ARTERIOSCLEROSIS 1 0.0004
273 LIPOMA 1 0.0004
274 ACTINIC KERATOSIS 1 0.0004
275 END STAGE RENAL DISEASE 7 0.0004
276 BLOOD LACTIC ACID INCREASED 2 0.0004
277 RESPIRATORY TRACT CONGESTION 6 0.0004
278 OBESITY 6 0.0004
279 PHARYNGOLARYNGEAL PAIN 2 0.0004
280 ANIMAL BITE 1 0.0004
281 ANGIONEUROTIC OEDEMA 1 0.0004
282 LARYNGOSPASM 1 0.0004
283 MELAENA 8 0.0004
284 DRUG SCREEN FALSE POSITIVE 1 0.0004
285 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
286 DIABETIC COMA 1 0.0004
287 ATYPICAL FEMUR FRACTURE 1 0.0004
288 EYE INFECTION 4 0.0004
289 NECK MASS 1 0.0004
290 BRONCHOSPASM 5 0.0004
291 EXERCISE TOLERANCE DECREASED 2 0.0003
292 MYOPATHY 3 0.0003
293 MUSCLE STRAIN 3 0.0003
294 EYELID MARGIN CRUSTING 1 0.0003
295 HYPERVENTILATION 2 0.0003
296 LUMBAR SPINAL STENOSIS 1 0.0003
297 RESPIRATORY RATE INCREASED 3 0.0003
298 CATARACT OPERATION 2 0.0003
299 EMBOLISM VENOUS 1 0.0003
300 SKIN LESION 9 0.0003
301 PNEUMONIA BACTERIAL 3 0.0003
302 DYSAESTHESIA 1 0.0003
303 SPINAL OPERATION 4 0.0003
304 NEPHROPATHY 3 0.0003
305 INFUSION SITE EXTRAVASATION 2 0.0003
306 PRE-EXISTING CONDITION IMPROVED 2 0.0003
307 BLOOD BLISTER 1 0.0003
308 INFUSION SITE PRURITUS 1 0.0003
309 BLADDER PAIN 1 0.0003
310 DYSPHONIA 18 0.0003
311 FACET JOINT SYNDROME 1 0.0003
312 BACTERIAL SEPSIS 1 0.0003
313 LYMPHOCYTE COUNT INCREASED 1 0.0003
314 HEPATOMEGALY 3 0.0003
315 SOMNAMBULISM 2 0.0003
316 INFUSION SITE HAEMORRHAGE 1 0.0003
317 POOR QUALITY DEVICE USED 3 0.0003
318 POST-TRAUMATIC STRESS DISORDER 2 0.0003
319 SINUS CONGESTION 4 0.0003
320 WRONG PRODUCT ADMINISTERED 2 0.0003
321 CLOSTRIDIAL INFECTION 1 0.0003
322 HEPATIC CYST 1 0.0003
323 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 5 0.0003
324 SINUSITIS 30 0.0003
325 OSTEOPOROSIS 12 0.0003
326 ANAPHYLACTIC REACTION 16 0.0003
327 DROOLING 2 0.0003
328 GRANULOMA 1 0.0003
329 AORTIC STENOSIS 1 0.0003
330 EAR PRURITUS 1 0.0003
331 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
332 BRONCHIOLITIS 1 0.0003
333 FULL BLOOD COUNT ABNORMAL 3 0.0003
334 MACULOPATHY 1 0.0003
335 CONJUNCTIVAL HYPERAEMIA 1 0.0003
336 NEUTROPENIC SEPSIS 2 0.0003
337 APPARENT DEATH 1 0.0003
338 BONE LESION 1 0.0003
339 VISUAL FIELD DEFECT 2 0.0003
340 SKIN LACERATION 3 0.0003
341 DEVICE KINK 1 0.0003
342 CAROTID ARTERY OCCLUSION 1 0.0003
343 CARDIOMYOPATHY 4 0.0003
344 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 14 0.0003
345 EYE PRURITUS 9 0.0003
346 DERMATITIS CONTACT 3 0.0003
347 MICTURITION URGENCY 3 0.0003
348 COMMUNICATION DISORDER 1 0.0003
349 GINGIVAL DISORDER 1 0.0003
350 PANIC DISORDER 1 0.0003
351 CHILLS 30 0.0003
352 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
353 GINGIVAL PAIN 2 0.0003
354 FOREIGN BODY 1 0.0002
355 TACHYCARDIA 22 0.0002
356 DERMATITIS ATOPIC 13 0.0002
357 BACK DISORDER 4 0.0002
358 HYPERURICAEMIA 1 0.0002
359 BRONCHITIS 18 0.0002
360 ANAPHYLACTOID REACTION 1 0.0002
361 CONGESTIVE CARDIOMYOPATHY 1 0.0002
362 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
363 SENSATION OF FOREIGN BODY 2 0.0002
364 AORTIC VALVE INCOMPETENCE 1 0.0002
365 ABSCESS LIMB 1 0.0002
366 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
367 ABNORMAL SENSATION IN EYE 1 0.0002
368 HORDEOLUM 1 0.0002
369 MONOPLEGIA 1 0.0002
370 IMMOBILE 1 0.0002
371 MELANOCYTIC NAEVUS 1 0.0002
372 DYSPHEMIA 1 0.0002
373 ONYCHOMYCOSIS 1 0.0002
374 TOOTH INFECTION 3 0.0002
375 PARONYCHIA 1 0.0002
376 HAEMORRHAGIC ANAEMIA 1 0.0002
377 GRIP STRENGTH DECREASED 2 0.0002
378 LIGAMENT RUPTURE 1 0.0002
379 CATHETERISATION CARDIAC 1 0.0002
380 EAR INFECTION 6 0.0002
381 DRY SKIN 30 0.0002
382 CHRONIC KIDNEY DISEASE 17 0.0002
383 MENINGITIS ASEPTIC 1 0.0002
384 PAPILLOEDEMA 1 0.0002
385 DRUG EFFECT DELAYED 1 0.0002
386 LUPUS-LIKE SYNDROME 2 0.0002
387 HAEMOGLOBIN INCREASED 1 0.0002
388 INJECTION SITE PAPULE 1 0.0002
389 ORAL DISCOMFORT 3 0.0002
390 CONJUNCTIVITIS 4 0.0002
391 PRODUCT DISTRIBUTION ISSUE 2 0.0002
392 THINKING ABNORMAL 4 0.0002
393 MULTIPLE MYELOMA 1 0.0002
394 GASTRITIS EROSIVE 1 0.0002
395 BLINDNESS UNILATERAL 3 0.0002
396 SINUS TACHYCARDIA 3 0.0002
397 ECZEMA 11 0.0002
398 GESTATIONAL DIABETES 1 0.0002
399 NON-SMALL CELL LUNG CANCER 1 0.0002
400 INFECTION 30 0.0002
401 FLUID OVERLOAD 3 0.0002
402 HORMONE LEVEL ABNORMAL 1 0.0002
403 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
404 PANCREATIC DISORDER 1 0.0002
405 SKIN HAEMORRHAGE 3 0.0002
406 LIGAMENT SPRAIN 2 0.0002
407 DIABETIC NEUROPATHY 1 0.0002
408 ANEURYSM 1 0.0002
409 HYPERAMMONAEMIA 1 0.0002
410 SALIVARY HYPERSECRETION 2 0.0002
411 COUGH 56 0.0002
412 CORONARY ARTERY STENOSIS 1 0.0002
413 LACRIMATION INCREASED 6 0.0002
414 BLOOD COUNT ABNORMAL 3 0.0002
415 OSTEOPENIA 3 0.0002
416 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
417 INSURANCE ISSUE 3 0.0002
418 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
419 DYSPNOEA 110 0.0002
420 TEMPERATURE INTOLERANCE 2 0.0002
421 FAILURE TO THRIVE 1 0.0002
422 EYE DISCHARGE 2 0.0002
423 BRAIN FOG 3 0.0002
424 JOINT STIFFNESS 5 0.0002
425 SCRATCH 2 0.0002
426 FOOD POISONING 1 0.0002
427 COMPRESSION FRACTURE 1 0.0002
428 IRRITABLE BOWEL SYNDROME 4 0.0002
429 FEAR 5 0.0002
430 DECREASED ACTIVITY 2 0.0002
431 CHEILITIS 1 0.0002
432 ERYTHEMA OF EYELID 1 0.0002
433 JAW DISORDER 1 0.0002
434 FAECALOMA 1 0.0002
435 NONSPECIFIC REACTION 1 0.0002
436 ASTHENOPIA 1 0.0002
437 PHOTOSENSITIVITY REACTION 3 0.0002
438 CHOKING SENSATION 1 0.0002
439 HYPERKERATOSIS 1 0.0002
440 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
441 SKIN DISORDER 6 0.0002
442 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
443 REBOUND EFFECT 2 0.0002
444 PERIORBITAL SWELLING 1 0.0002
445 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
446 NEUTROPHILIA 1 0.0002
447 GRANULOCYTOPENIA 1 0.0002
448 INTERNAL HAEMORRHAGE 2 0.0002
449 MUSCULOSKELETAL DISCOMFORT 3 0.0002
450 METASTASES TO LUNG 2 0.0002
451 METABOLIC DISORDER 1 0.0002
452 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
453 NASAL CONGESTION 10 0.0002
454 HEAD DISCOMFORT 3 0.0002
455 ENERGY INCREASED 1 0.0002
456 BRADYKINESIA 1 0.0002
457 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
458 CARDIAC PACEMAKER INSERTION 1 0.0002
459 ODYNOPHAGIA 1 0.0002
460 HYPERSENSITIVITY 31 0.0002
461 GANGRENE 1 0.0002
462 ILLNESS 17 0.0002
463 ADRENAL INSUFFICIENCY 2 0.0002
464 INJECTION SITE URTICARIA 4 0.0002
465 SMALL INTESTINAL OBSTRUCTION 2 0.0002
466 PIGMENTATION DISORDER 1 0.0002
467 PHARYNGITIS 2 0.0002
468 NASAL DRYNESS 1 0.0002
469 PHOTOPHOBIA 3 0.0002
470 BLEPHAROSPASM 1 0.0002
471 MULTIPLE INJURIES 1 0.0002
472 FLUID RETENTION 8 0.0002
473 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
474 ROTATOR CUFF SYNDROME 2 0.0002
475 INFUSION SITE PAIN 2 0.0002
476 ANOREXIA 2 0.0002
477 NIGHT SWEATS 5 0.0002
478 HERNIA 3 0.0002
479 ANGINA UNSTABLE 1 0.0002
480 HEPATITIS ACUTE 1 0.0002
481 HAEMORRHOIDS 3 0.0002
482 CHOKING 3 0.0002
483 POLYP 1 0.0002
484 PULMONARY CONGESTION 2 0.0002
485 SARS-COV-2 TEST POSITIVE 2 0.0002
486 HAEMATOCRIT DECREASED 3 0.0002
487 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
488 DYSMENORRHOEA 2 0.0002
489 EYE HAEMORRHAGE 2 0.0001
490 MENINGITIS 1 0.0001
491 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
492 JOINT RANGE OF MOTION DECREASED 2 0.0001
493 BREAST MASS 1 0.0001
494 FULL BLOOD COUNT DECREASED 3 0.0001
495 BRONCHIECTASIS 1 0.0001
496 METASTASES TO LYMPH NODES 1 0.0001
497 EXTRA DOSE ADMINISTERED 6 0.0001
498 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
499 IMPAIRED GASTRIC EMPTYING 2 0.0001
500 MIGRAINE 14 0.0001
501 DEVICE DELIVERY SYSTEM ISSUE 4 0.0001
502 LYMPHOEDEMA 1 0.0001
503 DISEASE PROGRESSION 17 0.0001
504 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
505 DEVICE OCCLUSION 2 0.0001
506 PNEUMONIA 46 0.0001
507 SLEEP DISORDER 10 0.0001
508 HAND FRACTURE 1 0.0001
509 DIALYSIS 2 0.0001
510 MUSCULAR WEAKNESS 16 0.0001
511 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
512 HYPERSOMNIA 4 0.0001
513 RHINORRHOEA 9 0.0001
514 CELLULITIS 7 0.0001
515 PRURITUS GENERALISED 3 0.0001
516 PARAESTHESIA ORAL 2 0.0001
517 PANIC REACTION 1 0.0001
518 HYPOKINESIA 2 0.0001
519 INTENTIONAL UNDERDOSE 1 0.0001
520 BLINDNESS TRANSIENT 1 0.0001
521 CEREBRAL DISORDER 1 0.0001
522 ARTHROPOD BITE 1 0.0001
523 SNEEZING 3 0.0001
524 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
525 THROAT IRRITATION 6 0.0001
526 HYDRONEPHROSIS 1 0.0001
527 DISCOMFORT 8 0.0001
528 NEPHROLITHIASIS 6 0.0001
529 INJECTION SITE RASH 4 0.0001
530 PHARYNGEAL OEDEMA 2 0.0001
531 DISTURBANCE IN ATTENTION 7 0.0001
532 FOOD ALLERGY 1 0.0001
533 MUSCULOSKELETAL CHEST PAIN 2 0.0001
534 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
535 TENDONITIS 2 0.0001
536 SWELLING 12 0.0001
537 THERAPY PARTIAL RESPONDER 2 0.0001
538 SWOLLEN TONGUE 4 0.0001
539 PRURITUS 49 0.0001
540 AFFECTIVE DISORDER 1 0.0001
541 FURUNCLE 1 0.0001
542 URTICARIA 21 0.0001
543 ATRIAL FLUTTER 1 0.0001
544 PRODUCT QUALITY ISSUE 17 0.0001
545 BLOOD PRESSURE FLUCTUATION 3 0.0001
546 OXYGEN SATURATION DECREASED 7 0.0001
547 ABDOMINAL DISTENSION 13 0.0001
548 MYASTHENIA GRAVIS 1 0.0001
549 MUSCLE TIGHTNESS 2 0.0001
550 FIBROMYALGIA 3 0.0001
551 PRESYNCOPE 3 0.0001
552 NEURALGIA 3 0.0001
553 DECUBITUS ULCER 1 0.0001
554 LUNG DISORDER 6 0.0001
555 POLYURIA 1 0.0001
556 HYPERAESTHESIA 1 0.0001
557 HAIR DISORDER 1 0.0001
558 MENSTRUAL DISORDER 1 0.0001
559 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
560 DRY EYE 6 0.0001
561 TYPE 2 DIABETES MELLITUS 4 0.0001
562 INFUSION SITE ERYTHEMA 1 0.0001
563 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
564 SCAR 2 0.0001
565 CARDIAC OPERATION 1 0.0001
566 EXPOSURE VIA SKIN CONTACT 3 0.0001
567 HYSTERECTOMY 1 0.0001
568 RESPIRATORY TRACT INFECTION 3 0.0001
569 CONDITION AGGRAVATED 35 0.0001
570 LOCAL SWELLING 2 0.0001
571 EOSINOPHILIA 2 0.0001
572 BLOOD CALCIUM INCREASED 1 0.0001
573 HYPOAESTHESIA 17 0.0001
574 IMMUNOSUPPRESSION 1 0.0001
575 LYMPHADENOPATHY 4 0.0001
576 FACIAL PAIN 1 0.0001
577 FATIGUE 87 0.0001
578 ASTHENIA 42 0.0001
579 JAUNDICE 3 0.0001
580 GOUT 2 0.0001
581 URINARY TRACT INFECTION 19 0.0001
582 SYNOVITIS 2 0.0001
583 OROPHARYNGEAL DISCOMFORT 1 0.0001
584 OEDEMA 6 0.0001
585 LIMB INJURY 3 0.0001
586 EXOSTOSIS 1 0.0001
587 SKIN DISCOLOURATION 5 0.0001
588 DYSURIA 4 0.0001
589 TREMOR 18 0.0001
590 IRON DEFICIENCY ANAEMIA 1 0.0001
591 BLOOD GLUCOSE ABNORMAL 2 0.0001
592 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
593 RASH 47 0.0001
594 PERSONALITY CHANGE 1 0.0001
595 EYE SWELLING 4 0.0001
596 HEPATIC STEATOSIS 2 0.0001
597 DIARRHOEA HAEMORRHAGIC 1 0.0001
598 BLISTER 6 0.0001
599 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
600 SKIN EXFOLIATION 9 0.0001
601 BLOOD SODIUM DECREASED 2 0.0001
602 FOOT FRACTURE 2 0.0001
603 INTENTIONAL DOSE OMISSION 3 0.0001
604 INCREASED APPETITE 2 0.0001
605 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
606 PRODUCT SUBSTITUTION ISSUE 6 0.0001
607 POST PROCEDURAL COMPLICATION 2 0.0001
608 DRUG PRESCRIBING ERROR 2 0.0001
609 GLAUCOMA 2 0.0001
610 ATELECTASIS 1 0.0001
611 PRESCRIBED OVERDOSE 2 0.0001
612 DIZZINESS POSTURAL 1 0.0001
613 NEEDLE ISSUE 3 0.0001
614 EAR PAIN 2 0.0001
615 ORAL HERPES 2 0.0001
616 BONE PAIN 6 0.0001
617 PHARYNGEAL SWELLING 1 0.0001
618 COELIAC DISEASE 1 0.0001
619 PAIN IN EXTREMITY 30 0.0001
620 KNEE OPERATION 1 0.0001
621 BODY TEMPERATURE DECREASED 1 0.0001
622 HOSPICE CARE 1 0.0001
623 CATARACT 6 0.0001
624 BLADDER DISORDER 1 0.0001
625 BLOOD PRESSURE ABNORMAL 2 0.0001
626 BLOOD POTASSIUM DECREASED 3 0.0001
627 THERAPEUTIC RESPONSE DECREASED 6 0.0001
628 EYELID PTOSIS 1 0.0001
629 RENAL FAILURE 13 0.0001
630 NEUTROPHIL COUNT INCREASED 1 0.0001
631 INITIAL INSOMNIA 1 0.0001
632 EAR DISCOMFORT 1 0.0001
633 EMOTIONAL DISORDER 3 0.0001
634 INJECTION SITE WARMTH 2 0.0001
635 RIB FRACTURE 2 0.0001
636 OROPHARYNGEAL PAIN 9 0.0001
637 LIMB DISCOMFORT 3 0.0001
638 NERVOUS SYSTEM DISORDER 3 0.0001
639 MALAISE 42 0.0001
640 NERVOUSNESS 5 0.0001
641 INTENTIONAL DRUG MISUSE 2 0.0001
642 JOINT DISLOCATION 1 0.0001
643 OSTEOARTHRITIS 4 0.0001
644 JOINT INJURY 2 0.0001
645 BODY HEIGHT DECREASED 1 0.0001
646 MOVEMENT DISORDER 3 0.0001
647 HIP FRACTURE 3 0.0001
648 HEREDITARY ANGIOEDEMA 1 0.0001
649 BREAST CANCER METASTATIC 1 0.0001
650 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
651 BIPOLAR DISORDER 1 0.0001
652 DIABETES MELLITUS 7 0.0001
653 PRODUCT PRESCRIBING ISSUE 2 0.0001
654 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
655 OESOPHAGITIS 1 0.0001
656 DYSPEPSIA 9 0.0001
657 BLOOD GLUCOSE FLUCTUATION 1 0.0001
658 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
659 GASTROINTESTINAL PAIN 1 0.0001
660 INSOMNIA 24 0.0001
661 TOOTH DISORDER 2 0.0001
662 NERVE INJURY 1 0.0001
663 INFLUENZA 10 0.0001
664 GLOSSODYNIA 2 0.0001
665 ORAL PAIN 2 0.0001
666 DEVICE ISSUE 8 0.0001
667 NEPHROPATHY TOXIC 1 0.0001
668 FISTULA 1 0.0001
669 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
670 EYE PAIN 5 0.0001
671 NO ADVERSE EVENT 16 0.0001
672 DIZZINESS 44 0.0001
673 IMPAIRED DRIVING ABILITY 1 0.0001
674 MEMORY IMPAIRMENT 12 0.0001
675 INJECTION SITE REACTION 6 0.0001
676 TINNITUS 4 0.0001
677 EYE IRRITATION 5 0.0001
678 NASOPHARYNGITIS 16 0.0001
679 PYREXIA 30 0.0001
680 MADAROSIS 1 0.0001
681 RASH MACULAR 3 0.0001
682 BURNING SENSATION 6 0.0001
683 PRODUCT USE ISSUE 16 0.0001
684 COVID-19 PNEUMONIA 1 0.0001
685 OCULAR HYPERAEMIA 4 0.0001
686 BLOOD IRON DECREASED 1 0.0001
687 COMPLETED SUICIDE 7 0.0001
688 MYOCLONUS 1 0.0001
689 MACULAR DEGENERATION 1 0.0001
690 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
691 CRYING 3 0.0001
692 HYPOGLYCAEMIA 4 0.0001
693 PANIC ATTACK 3 0.0001
694 ILL-DEFINED DISORDER 5 0.0001
695 MUSCLE SPASTICITY 1 0.0001
696 INJECTION SITE EXTRAVASATION 1 0.0001
697 ABNORMAL WEIGHT GAIN 1 0.0001
698 ABASIA 2 0.0001
699 GENERALISED OEDEMA 1 0.0001
700 CYST 1 0.0001
701 ILEUS 1 0.0001
702 HAIR COLOUR CHANGES 1 0.0001
703 HOT FLUSH 6 0.0001
704 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
705 BRAIN OEDEMA 1 0.0001
706 ANAEMIA 15 0.0001
707 INJECTION SITE IRRITATION 1 0.0001
708 ACUTE KIDNEY INJURY 12 0.0001
709 INJECTION SITE SWELLING 6 0.0001
710 INTRAOCULAR PRESSURE INCREASED 1 0.0001
711 HEPATITIS 2 0.0001
712 ERECTILE DYSFUNCTION 2 0.0001
713 BACK PAIN 18 0.0001
714 SKIN ULCER 2 0.0001
715 INJECTION SITE INDURATION 1 0.0001
716 SWELLING FACE 5 0.0001
717 MUSCLE SPASMS 14 0.0001
718 ARTHRITIS 6 0.0001
719 PARAESTHESIA 12 0.0001
720 ANHEDONIA 2 0.0001
721 INCORRECT PRODUCT STORAGE 1 0.0001
722 CHEST PAIN 14 0.0001
723 INJECTION SITE BRUISING 6 0.0001
724 HEADACHE 47 0.0001
725 HAIR TEXTURE ABNORMAL 1 0.0001
726 DEPRESSION 17 0.0001
727 PAIN OF SKIN 2 0.0001
728 DRUG EFFECT DECREASED 4 0.0001
729 COVID-19 13 0.0001
730 DRY MOUTH 6 0.0001
731 THROAT TIGHTNESS 2 0.0001
732 PALLOR 2 0.0001
733 DRUG TOXICITY 1 0.0001
734 DECREASED APPETITE 17 0.0001
735 DEVICE MECHANICAL ISSUE 1 0.0001
736 CORONARY ARTERY OCCLUSION 1 0.0001
737 VISION BLURRED 10 0.0001
738 PERIPHERAL COLDNESS 1 0.0001
739 DIVERTICULITIS 2 0.0001
740 ARTHRALGIA 30 0.0001
741 PROCEDURAL PAIN 2 0.0001
742 MENTAL STATUS CHANGES 2 0.0001
743 POLLAKIURIA 3 0.0001
744 WEIGHT DECREASED 20 0.0001
745 NECK PAIN 4 0.0001
746 PANCYTOPENIA 4 0.0001
747 MASS 1 0.0001
748 CARPAL TUNNEL SYNDROME 1 0.0001
749 BLOOD TEST ABNORMAL 1 0.0001
750 LOSS OF CONSCIOUSNESS 9 0.0001
751 PAIN 43 0.0001
752 THERAPY INTERRUPTED 5 0.0001
753 RED BLOOD CELL COUNT DECREASED 2 0.0001
754 CARDIOGENIC SHOCK 1 0.0001
755 BALANCE DISORDER 6 0.0001
756 PANCREATIC CARCINOMA 2 0.0001
757 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
758 INTENTIONAL PRODUCT MISUSE 6 0.0001
759 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
760 ASCITES 2 0.0001
761 LABORATORY TEST ABNORMAL 2 0.0001
762 URINARY INCONTINENCE 2 0.0001
763 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
764 DEHYDRATION 9 0.0001
765 IMMUNODEFICIENCY 1 0.0001
766 GASTROINTESTINAL DISORDER 6 0.0001
767 IRRITABILITY 4 0.0001
768 HYPOAESTHESIA ORAL 1 0.0001
769 JOINT SWELLING 8 0.0001
770 UNEVALUABLE EVENT 5 0.0001
771 ECONOMIC PROBLEM 1 0.0001
772 STOMATITIS 4 0.0001
773 HIP ARTHROPLASTY 1 0.0001
774 PERIPHERAL SWELLING 10 0.0001
775 ANKLE FRACTURE 1 0.0001
776 INJECTION SITE ERYTHEMA 8 0.0001
777 NAUSEA 51 0.0001
778 RENAL DISORDER 3 0.0001
779 COGNITIVE DISORDER 3 0.0001
780 DYSPHAGIA 6 0.0001
781 FALL 21 0.0001
782 PNEUMOTHORAX 1 0.0001
783 DRUG INTERACTION 10 0.0001
784 CYSTITIS 2 0.0001
785 MOOD SWINGS 2 0.0001
786 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
787 BLOOD POTASSIUM INCREASED 1 0.0001
788 HYPERTENSION 13 0.0001
789 PRODUCT DOSE OMISSION ISSUE 18 0.0001
790 ALOPECIA 12 0.0001
791 METASTASES TO BONE 1 0.0001
792 IMPAIRED HEALING 2 0.0001
793 MANIA 1 0.0001
794 STAPHYLOCOCCAL INFECTION 2 0.0001
795 VIRAL INFECTION 2 0.0001
796 COAGULOPATHY 1 0.0001
797 URINARY RETENTION 2 0.0001
798 ANXIETY 17 0.0001
799 CANDIDA INFECTION 1 0.0001
800 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
801 ANGER 2 0.0001
802 BLOOD PRESSURE INCREASED 9 0.0001
803 MYALGIA 10 0.0001
804 INJECTION SITE PAIN 18 0.0001
805 HEPATIC ENZYME INCREASED 4 0.0001
806 HAEMATURIA 2 0.0001
807 GASTRIC DISORDER 2 0.0001
808 NIGHTMARE 2 0.0001
809 DEVICE DEFECTIVE 1 0.0001
810 ORTHOSTATIC HYPOTENSION 1 0.0001
811 MUSCULOSKELETAL PAIN 3 0.0001
812 METASTASES TO LIVER 1 0.0001
813 HYPOXIA 2 0.0001
814 PANCREATITIS 3 0.0001
815 DEPRESSED MOOD 3 0.0001
816 LYMPHOCYTE COUNT DECREASED 1 0.0001
817 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
818 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
819 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
820 GASTROENTERITIS VIRAL 1 0.0001
821 RASH PRURITIC 3 0.0001
822 LEUKOCYTOSIS 1 0.0001
823 DRUG EFFECT INCOMPLETE 2 0.0001
824 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
825 BONE DISORDER 1 0.0001
826 OFF LABEL USE 48 0.0001
827 DIARRHOEA 35 0.0001
828 BACTERIAL INFECTION 1 0.0001
829 WEIGHT INCREASED 12 0.0001
830 FLATULENCE 3 0.0001
831 HYPOCALCAEMIA 1 0.0001
832 COLITIS 2 0.0001
833 BLOOD URINE PRESENT 1 0.0001
834 FEELING JITTERY 1 0.0001
835 HERPES ZOSTER 3 0.0001
836 CONTUSION 5 0.0001
837 ABDOMINAL PAIN 12 0.0001
838 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
839 PALPITATIONS 6 0.0001
840 KIDNEY INFECTION 1 0.0001
841 DISABILITY 1 0.0001
842 HEART RATE INCREASED 5 0.0001
843 SOMNOLENCE 10 0.0000
844 DRUG INEFFECTIVE 65 0.0000
845 OEDEMA PERIPHERAL 6 0.0000
846 DYSKINESIA 2 0.0000
847 INJURY ASSOCIATED WITH DEVICE 1 0.0000
848 BLINDNESS 2 0.0000
849 BODY TEMPERATURE INCREASED 1 0.0000
850 INFLUENZA LIKE ILLNESS 4 0.0000
851 VISUAL IMPAIRMENT 6 0.0000
852 INCORRECT DOSE ADMINISTERED 11 0.0000
853 RHABDOMYOLYSIS 2 0.0000
854 ROAD TRAFFIC ACCIDENT 2 0.0000
855 ABDOMINAL DISCOMFORT 8 0.0000
856 WITHDRAWAL SYNDROME 2 0.0000
857 GAIT DISTURBANCE 9 0.0000
858 IMPAIRED WORK ABILITY 1 0.0000
859 HYPOACUSIS 2 0.0000
860 DEEP VEIN THROMBOSIS 3 0.0000
861 MENTAL DISORDER 2 0.0000
862 PRODUCT DOSE OMISSION 3 0.0000
863 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
864 HOSPITALISATION 7 0.0000
865 INFUSION RELATED REACTION 3 0.0000
866 ANGIOEDEMA 2 0.0000
867 INJECTION SITE PRURITUS 3 0.0000
868 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
869 ADVERSE DRUG REACTION 4 0.0000
870 THERAPY NON-RESPONDER 2 0.0000
871 PANCREATITIS ACUTE 1 0.0000
872 HEART RATE IRREGULAR 1 0.0000
873 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
874 ERYTHEMA 9 0.0000
875 HYPOKALAEMIA 2 0.0000
876 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
877 CARDIAC DISORDER 4 0.0000
878 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
879 PULMONARY EMBOLISM 4 0.0000
880 NEUROPATHY PERIPHERAL 4 0.0000
881 SKIN BURNING SENSATION 3 0.0000
882 BLOOD GLUCOSE DECREASED 2 0.0000
883 LOCALISED INFECTION 1 0.0000
884 EMOTIONAL DISTRESS 5 0.0000
885 MENTAL IMPAIRMENT 1 0.0000
886 LIVER INJURY 1 0.0000
887 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
888 EPISTAXIS 3 0.0000
889 SYNCOPE 4 0.0000
890 FLUSHING 4 0.0000
891 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
892 THERAPY CESSATION 2 0.0000
893 DRUG RESISTANCE 1 0.0000
894 HYPERHIDROSIS 5 0.0000
895 DRUG DOSE OMISSION BY DEVICE 3 0.0000
896 INJECTION SITE HAEMORRHAGE 3 0.0000
897 FEELING ABNORMAL 9 0.0000
898 PLATELET COUNT DECREASED 4 0.0000
899 FREQUENT BOWEL MOVEMENTS 1 0.0000
900 PNEUMONITIS 1 0.0000
901 CONSTIPATION 8 0.0000
902 MOOD ALTERED 1 0.0000
903 HAEMATOCHEZIA 2 0.0000
904 VOMITING 17 0.0000
905 FEELING COLD 1 0.0000
906 HAEMOPTYSIS 1 0.0000
907 LETHARGY 2 0.0000
908 SEIZURE 4 0.0000
909 MYOCARDIAL INFARCTION 6 0.0000
910 LIVER FUNCTION TEST ABNORMAL 1 0.0000
911 MUSCULOSKELETAL STIFFNESS 3 0.0000
912 ABDOMINAL PAIN UPPER 7 0.0000
913 HEPATIC FAILURE 1 0.0000
914 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
915 CORONARY ARTERY DISEASE 1 0.0000
916 PLEURAL EFFUSION 2 0.0000
917 VERTIGO 2 0.0000
918 SUICIDAL IDEATION 3 0.0000
919 BONE DENSITY DECREASED 1 0.0000
920 HEAD INJURY 1 0.0000
921 METABOLIC ACIDOSIS 1 0.0000
922 INTENTIONAL OVERDOSE 2 0.0000
923 DRUG INTOLERANCE 3 0.0000
924 CONFUSIONAL STATE 5 0.0000
925 ATRIAL FIBRILLATION 3 0.0000
926 AMNESIA 2 0.0000
927 PSORIASIS 4 0.0000
928 OSTEONECROSIS 1 0.0000
929 EYE DISORDER 1 0.0000
930 BLOOD PRESSURE DECREASED 2 0.0000
931 EXPIRED PRODUCT ADMINISTERED 1 0.0000
932 LIP SWELLING 1 0.0000
933 FUNGAL INFECTION 1 0.0000
934 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
935 HAEMOGLOBIN DECREASED 3 0.0000
936 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
937 DELIRIUM 1 0.0000
938 DEVICE USE ERROR 1 0.0000
939 NEOPLASM PROGRESSION 1 0.0000
940 HYPERKALAEMIA 1 0.0000
941 HEART RATE DECREASED 1 0.0000
942 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
943 CEREBRAL HAEMORRHAGE 1 0.0000
944 MOBILITY DECREASED 2 0.0000
945 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
946 UNDERDOSE 2 0.0000
947 AGITATION 2 0.0000
948 INJECTION SITE MASS 1 0.0000
949 DYSGEUSIA 2 0.0000
950 DYSARTHRIA 1 0.0000
951 RHEUMATOID ARTHRITIS 3 0.0000
952 ACNE 2 0.0000
953 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
954 PLASMA CELL MYELOMA 1 0.0000
955 ABNORMAL BEHAVIOUR 1 0.0000
956 HYPOTENSION 5 0.0000
957 CARDIAC FAILURE 2 0.0000
958 THROMBOSIS 2 0.0000
959 LUNG NEOPLASM MALIGNANT 1 0.0000
960 CARDIO-RESPIRATORY ARREST 1 0.0000
961 TOXICITY TO VARIOUS AGENTS 4 0.0000
962 PRODUCT STORAGE ERROR 2 0.0000
963 BREAST CANCER 2 0.0000
964 BLOOD GLUCOSE INCREASED 4 0.0000
965 ARRHYTHMIA 1 0.0000
966 DISEASE RECURRENCE 1 0.0000
967 DEATH 18 0.0000
968 INTERSTITIAL LUNG DISEASE 1 0.0000
969 AGGRESSION 1 0.0000
970 INFLAMMATION 1 0.0000
971 HAEMORRHAGE 2 0.0000
972 BRADYCARDIA 1 0.0000
973 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
974 ARTHROPATHY 1 0.0000
975 SEPSIS 2 0.0000
976 THROMBOCYTOPENIA 2 0.0000
977 HYPONATRAEMIA 1 0.0000
978 CEREBROVASCULAR ACCIDENT 3 0.0000
979 CONVULSION 1 0.0000
980 FEELING HOT 1 0.0000
981 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
982 EXPOSURE DURING PREGNANCY 1 0.0000
983 FEBRILE NEUTROPENIA 1 0.0000
984 NEOPLASM MALIGNANT 1 0.0000
985 NEUTROPENIA 2 0.0000
986 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
987 DEVICE MALFUNCTION 1 0.0000
988 INJURY 1 0.0000
989 HALLUCINATION 1 0.0000
990 CARDIAC FAILURE CONGESTIVE 1 0.0000
991 DRUG DOSE OMISSION 2 0.0000
992 DRUG WITHDRAWAL SYNDROME 1 0.0000
993 ADVERSE EVENT 1 0.0000
994 OVERDOSE 2 0.0000